Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, Arca, Artax, AVM, Evgen, Innovent, Moleculin, Oryzon, Targovax, Valo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affinivax, Akeso, Ascletis, Asieris, Cyclacel, Emalex, Ena, Equillium, Galecto, Genocea, Hepion, Inhibrx, Jupiter, Kedrion, Lava, Scynexis, Strongbridge, TFF.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcam, Bicycle, Hoth, Hutchmed, Ionis, M8, Palisade Bio, Pionyr, RDIF, UCB.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Airstrip, Avita Biomedical, Biointellisense, Exactech, International Isotopes, Invivo Therapeutics, Radqual, RTI Surgical, Seegene, Symphonyai.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Antengene, Bayer, Chemocentryx, Coya, Diurnal, Enochian, Gensight, Inotrem, Iveric, Janssen, Kintor, Prilenia, Provention, Seagen, Sigilon, Sirnaomics, Soleno, Tetra, Tevogen, Valneva.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alterola, Abti, Aridis, Astellas, Blue Water, Cellectar, Etherna, Evgen, Evrys, Excellthera, Exevir, Heat, Intocell, Legochem, Probiogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Alvotech, Aptorum, Bergenbio, Bionomics, Caribou, Celldex, Enterome, Eyepoint, Gadeta, Galectin, Glycomimetics, Harbour, Inmune, Innovent, Nrx, Pharvaris, Quantum, Recce.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carrot, Quidel, Ortho Clinical Diagnostics, Uvision360.